UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Find the latest Super League Enterprise, Inc. (SLE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.